Use of mglur5 (esp. afq056) in gi (esp. gerd)

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4045 (2006.01) A61K 31/165 (2006.01) A61K 31/27 (2006.01) A61K 31/4035 (2006.01) A61K 31/4439 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61P 1/04 (2006.01) A61P 13/00 (2006.01)

Patent

CA 2614698

The invention relates to the use of a compound acting as mGluR5 antagonist in the treatment, preventions and/or delay of progression of disorders of the gastro-intestinal tract, disorders of the urinary tract and/or post-operative disorders and to the treatment, prevention and/or delay of progression of pain associated with these indications.

La présente invention concerne l'emploi d'un composé agissant en tant qu'antagoniste de mGluR5 dans le traitement, la prévention et/ou le retard de la progression de troubles du tractus gastro-intestinal, de troubles de l'appareil urinaire et/ou de troubles postopératoires. La présente invention concerne également le traitement, la prévention et/ou le retard de la progression des douleurs associées à ces pathologies.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of mglur5 (esp. afq056) in gi (esp. gerd) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of mglur5 (esp. afq056) in gi (esp. gerd), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mglur5 (esp. afq056) in gi (esp. gerd) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1467334

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.